US-based biotechnology company Atreca has secured $35m in a series B financing round led by Wellington Management Company.
The funds will be utilised to progress the development of the company’s antibody-based therapeutics.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Calithera Biosciences has announced a public offering of common stock shares to raise up to $50m.
The US-based clinical-stage pharmaceutical company plans to use the funds towards general corporate purposes.
Spring Bank Pharmaceuticals plans to raise up to $50m through a public offering of shares of its common stock.
US-based clinical-stage biopharmaceutical company Spring Bank plans to use the proceeds for general corporate purposes.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataCoherus BioSciences (formerly known as BioGenerics) has announced the private placement of six million shares of its common stock priced at $11.44 a share to raise $75m.
The company intends to raise a total of $150m in two tranches, with $75m to be raised in the first tranche.
The US-based biopharmaceutical company plans to use the funds towards the development of its pegfilgrastim biosimilar product candidate CHS-1701, as well as general corporate purposes.
